HIT Consultant August 8, 2024
What You Should Know:
– The healthcare venture capital landscape experienced a resurgence in the first half of 2024, according to a new report from Silicon Valley Bank (SVB). Despite ongoing economic challenges, 89% of US VC funds exceeding $25M successfully met their fundraising targets.
– The report, “2024 Mid-Year Healthcare Investments and Exits,” delves into venture capital activity across the healthcare sector, including biopharma, healthtech, medical device, and diagnostics/tools (dx/tools).
Key Findings from the SVB Mid-Year Healthcare Investments and Exits Report:
- Biopharma Sector Thrives: The biopharma sector continues to attract significant investor interest, with a record-breaking first half of the year for Series A investments. While rare disease funding is still below pre-pandemic levels, the sector shows...
Today's Sponsors
Today's Sponsor